FDA Finds No Clinical Differences in Novartis Biosimilar of Amgen Drug

Documents released in advance of an FDA advisory meeting stated no difference between Neupogen and Sandoz biosimilar
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news